During the last session, Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares were 7.85 million, with the beta value of the company hitting 1.08. At the end of the trading day, the stock’s price was $0.12, reflecting an intraday loss of -2.52% or -$0.01. The 52-week high for the CNSP share is $137.50, that puts it down -114483.33 from that peak though still a striking 16.67% gain since the share price plummeted to a 52-week low of $0.10. The company’s market capitalization is $7.11M, and the average intraday trading volume over the past 10 days was 10.24 million shares, and the average trade volume was 14.33 million shares over the past three months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Cns Pharmaceuticals Inc (CNSP) registered a -2.52% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.52% in intraday trading to $0.12, hitting a weekly high. The stock’s 5-day price performance is -0.72%, and it has moved by -21.12% in 30 days. Based on these gigs, the overall price performance for the year is -99.90%. The short interest in Cns Pharmaceuticals Inc (NASDAQ:CNSP) is 1.14 million shares and it means that shorts have 0.04 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $0.5, which implies an increase of 76.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $0.5 and $0.5 respectively. As a result, CNSP is trading at a discount of -316.67% off the target high and -316.67% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.98%.
CNSP Dividends
Cns Pharmaceuticals Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Cns Pharmaceuticals Inc insiders own 1.04% of total outstanding shares while institutional holders control 0.79%, with the float percentage being 0.80%.
